2023-05-30 05:55:35
UNußerdem geht es um Merck, Bristol Myers Squibb, Johnson&Johnson, Legend Biotech, AstraZeneca, Daiichi Sankyo, Astellas, Takeda, Pfizer, Abbvie, Lepu Biopharma, LegoChem, Novartis, Heidelberg Pharma, Immunogen, .JPMorgan Japan Research Enhanced Index Equity ESG ETF ( WKN : A2JAV13), JPMorgan Eurozone Research Enhanced Index Equity ESG ETF (WKN : A3DEH3), JPMorgan Global Research Enhanced Index Equity (WKN : A2DWM6), HSBC Multi Factor Worldwide Equity UCITS ETF (WKN : A116RM), Invesco Invesco Quantitative Strategie (WKN : A2JAV11), JPMorgan US Research Enhanced Index Equity (WKN : A2DWM7), Fidelity Sustainable Research Enhanced US Equity ETF (WKN : A2P0ZN), Ossiam ESG Low Carbon Shiller Barclays CAPE US Sector ETF (WKN : A2JFY6), Fidelity US Quality Income ETF (WKN : A2DL7C) et SPDR US Dividend Aristocrats (WKN : A1JKS0).
Abonnez-vous au podcast sur Spotify, Podcast Apple, Amazon Musique et Deezer. Ou directement par Flux RSS.
Vous pouvez trouver la newsletter AAA ici.
#Podcast #boursier #Pfizer #Merck #Daiichi #Sankyo #tels #sont #les #espoirs #succès #conférence #sur #cancer #lASCO
1685934374